— Know what they know.
Not Investment Advice

VERA NASDAQ

Vera Therapeutics, Inc.
1W: -13.2% 1M: -14.7% 3M: -17.7% YTD: -29.4% 1Y: +61.7% 3Y: +346.1% 5Y: +198.7%
$34.04
-0.31 (-0.90%)
 
Weekly Expected Move ±6.9%
$32 $35 $37 $40 $42
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 29 · $2.4B mcap · 58M float · 2.04% daily turnover · Short 50% of daily vol
Last Earnings 2026-05-07
EPS
$-1.69
▼ Miss -27.2%
Revenue
$426K
Est (actual pending)
Next Earnings 2026-08-06
EPS Estimate
$-1.60
Range: $-1.78 - $-1.32
Revenue Estimate
$1M
5 analysts

Estimate vs Actual

Earnings Surprise History

5/19
EPS Beats
0/19
Revenue Beats
26%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-21 quarter 2026-06-30 $-1.61 $-1.60 ▲ 0.01 $1,280,600 $1,280,600
2026-05-21 annual 2027-12-31 $-3.57 $-3.55 ▲ 0.02 $268,687,250 $268,687,250
2026-05-21 annual 2026-12-31 $-5.96 $-6.05 ▼ 0.09 $39,056,066 $39,591,199
2026-05-21 quarter 2026-12-31 $-1.22 $-1.25 ▼ 0.03 $36,555,842 $33,886,738
2026-05-21 quarter 2026-09-30 $-1.49 $-1.52 ▼ 0.03 $7,679,444 $7,131,500
2026-05-18 annual 2026-12-31 $-5.89 $-5.96 ▼ 0.07 $39,056,066 $39,056,066
2026-05-18 annual 2027-12-31 $-3.58 $-3.57 ▲ 0.01 $268,687,250 $268,687,250
2026-05-15 quarter 2027-06-30 $-1.02 $-0.96 ▲ 0.06 $37,317,500 $51,216,000
2026-05-15 annual 2030-12-31 $7.21 $7.33 ▲ 0.11 $1,508,001,250 $1,508,001,250
2026-05-15 quarter 2026-12-31 $-1.19 $-1.22 ▼ 0.03 $36,555,842 $36,555,842
2026-05-15 annual 2026-12-31 $-5.79 $-5.89 ▼ 0.10 $39,056,066 $39,056,066
2026-05-15 quarter 2026-06-30 $-1.57 $-1.61 ▼ 0.04 $1,280,600 $1,280,600
2026-05-15 quarter 2027-09-30 $-0.85 $-0.76 ▲ 0.10 $51,946,500 $69,983,200
2026-05-15 annual 2027-12-31 $-3.53 $-3.58 ▼ 0.05 $268,687,250 $268,687,250
2026-05-15 quarter 2027-03-31 $-1.08 $-1.04 ▲ 0.04 $34,589,600 $42,811,667
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms